Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0AB4Q
|
||||
Former ID |
DCL000551
|
||||
Drug Name |
Ispronicline
|
||||
Synonyms |
RJR 1734; TC 01734; AZD-3480; RJR-1734; Ispronicline (INN/USAN); (E)-N-methyl-5-(5-propan-2-yloxypyridin-3-yl)pent-4-en-2-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Schizophrenia; Alzheimer disease [ICD9: 295, 331.0; ICD10:F20, G30] | Discontinued in Phase 2 | [546915] | ||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H22N2O
|
||||
Canonical SMILES |
CC(C)OC1=CN=CC(=C1)C=CCC(C)NC
|
||||
InChI |
1S/C14H22N2O/c1-11(2)17-14-8-13(9-16-10-14)7-5-6-12(3)15-4/h5,7-12,15H,6H2,1-4H3/b7-5+/t12-/m0/s1
|
||||
InChIKey |
RPCVIAXDAUMJJP-PZBABLGHSA-N
|
||||
CAS Number |
CAS 482299-54-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.